Avastin in neovascular glaucoma

Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma

Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma from the February 2009 issue of the British Journal of Ophthalmology.

Please click here to read the full story.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.